QYUNS THERAPEUTICS

qyuns-therapeutics-logo

Qyuns is developing six candidates, most of them interleukin antibodies. It has two biosimilar drugs in China clinical trials, including a biosimilar to tocilizumab, a Chugai drug marketed as Actemra for various rheumatoid arthritis conditions.

#SimilarOrganizations #People #Financial #Website #More

QYUNS THERAPEUTICS

Industry:
Health Care Therapeutics

Founded:
2015-01-01

Address:
Taizhou, Jiangsu, China

Country:
China

Website Url:
http://www.qyuns.net

Total Employee:
51+

Status:
Active

Total Funding:
35.82 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Mobile Non Scaleable Content Euro ASP.NET IIS Pound Sterling Japanese Yen IIS 7


Similar Organizations

affimed-logo

Affimed

Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.

akebia-therapeutics-logo

Akebia Therapeutics

Akebia Therapeutics develops treatments for ischemia and vascular diseases.

lysosomal-therapeutics-logo

Lysosomal Therapeutics

Lysosomal Therapeutics deliver cures for neurodegenerative diseases.

pandion-therapeutics-logo

Pandion Therapeutics

Pandion Therapeutics develops innovative modular proteins, antibodies, and bispecifics for autoimmune and inflammatory diseases.

semma-therapeutics-logo

Semma Therapeutics

Semma Therapeutics was founded to develop transformative therapies for Type 1 diabetes patients.

Current Employees Featured

not_available_image

Jiwan Qiu
Jiwan Qiu Founder &CEO @ Qyuns Therapeutics
Founder &CEO

Founder


not_available_image

Jiwan Qiu

Investors List

shenzhen-kaiding-juncan-venture-cci-capital_image

Shenzhen Kaiding Juncan venture Cci Capital

Shenzhen Kaiding Juncan venture Cci Capital investment in Series C - Qyuns Therapeutics

triwise-capital_image

TriWise Capital

TriWise Capital investment in Series C - Qyuns Therapeutics

jiayin-investment_image

Jiayin Investment

Jiayin Investment investment in Series B - Qyuns Therapeutics

lucky-source-funds_image

Lucky Source Funds

Lucky Source Funds investment in Series B - Qyuns Therapeutics

triwise-capital_image

TriWise Capital

TriWise Capital investment in Series B - Qyuns Therapeutics

aplus-capital_image

Hongtai Capital Holdings

Hongtai Capital Holdings investment in Series B - Qyuns Therapeutics

hefu-ruitai_image

Hefu Ruitai

Hefu Ruitai investment in Series B - Qyuns Therapeutics

Official Site Inspections

http://www.qyuns.net Semrush global rank: 8.76 M Semrush visits lastest month: 261

  • Host name: 120.78.166.66
  • IP address: 120.78.166.66
  • Location: Hangzhou China
  • Latitude: 30.294
  • Longitude: 120.1619
  • Timezone: Asia/Shanghai

Loading ...

More informations about "Qyuns Therapeutics" on Search Engine